Parkinson's Disease Archives

Koneksa Press Release KH007 Topline Results thumbnail image

Koneksa Announces Positive Topline Results from KH007 Study Evaluating Digital Measures of Parkinson’s Disease Progression

By Koneksa HealthNews

Study meets primary compliance endpoint, reinforcing the value of Koneksa’s integrated measurement platform and syndicated, precompetitive study model with partners Merck and Regeneron. Punta Gorda, FL — September 1, 2026 —Koneksa Health...

September 1, 2026

The Complete Guide to the Finger Tap Test: What It Measures, How It Is Used, and Why Digital Approaches Are Changing What It Can Reveal

By Koneksa HealthArticle

The finger tap test is one of the oldest and most widely used motor assessments in clinical neuroscience. A clinician watches a patient tap as quickly as possible for a...

May 18, 2026

Koneksa Achieves Key Milestone with Database Lock for KH007 Study Evaluating Parkinson’s Disease Progression

By Koneksa HealthNews

Completion of data collection enables full analysis, with topline results expected in June 2026 New York, NY — 23 April 2026 — Koneksa, a measurement-science partner for clinical development,...

April 23, 2026

What Digital Measures Are Really Capturing in Parkinson’s Disease and Why It Matters for Clinical Trials

By Koneksa HealthArticle

Insights from new peer-reviewed research by Koneksa during Parkinson's Awareness Month Behind Every Dataset is a Lived Experience. In Parkinson’s disease, symptoms do not progress in neat, linear steps....

April 9, 2026

Celebrating Last Patient In for Koneksa’s Parkinson’s Disease Progression Study (KH007)

By Koneksa HealthNews

We are happy to announce that our clinical study KH007 (NCT06219629) of Disease Progression in Parkinson's Disease (PD) achieved the last patient in (LPI) on January 10, 2025. This is...

January 13, 2025

Celebrating Last Patient In for Koneksa’s Parkinson’s Disease Progression Study (KH007)

By Koneksa HealthArticle

We are happy to announce that our clinical study KH007 (NCT06219629) of Disease Progression in Parkinson's Disease (PD) achieved the last patient in (LPI) on January 10, 2025. This is...

January 13, 2025

Koneksa PD Day and MJFF

By Koneksa HealthArticle

In the same week that the Michael J. Fox Foundation (MJFF) held its 14th annual Parkinson’s Disease (PD) Therapeutics Conference in New York City, Koneksa held its inaugural PD Day....

October 22, 2024

Digital Health Takes Center Stage at the MDS Conference

By Koneksa HealthArticle

This year’s International Parkinson and Movement Disorder Society (MDS) was held over the last weekend of September in Philadelphia. The theme, “Movement Disorders in the Digital Age: Harnessing AI for...

October 9, 2024

Koneksa Announces Regeneron Joins Data Syndication Program for Parkinson’s Digital Biomarkers Study

By Koneksa HealthNews

NEW YORK--(BUSINESS WIRE)--Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today that Regeneron has become a member of its Data Syndication Program for the LEARNS observational study. This...

September 3, 2024

Koneksa Announces Merck Joins Data Syndication Partnership Program Around Parkinson’s Digital Biomarkers Observational Study

By Koneksa HealthNews

New York, NY – March 20, 2024 – Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced that Merck, known as MSD outside of the United States and Canada,...

March 20, 2024

Parkinson’s Disease

Koneksa Announces Positive Topline Results from KH007 Study Evaluating Digital Measures of Parkinson’s Disease Progression

The Complete Guide to the Finger Tap Test: What It Measures, How It Is Used, and Why Digital Approaches Are Changing What It Can Reveal

Koneksa Achieves Key Milestone with Database Lock for KH007 Study Evaluating Parkinson’s Disease Progression

What Digital Measures Are Really Capturing in Parkinson’s Disease and Why It Matters for Clinical Trials

Celebrating Last Patient In for Koneksa’s Parkinson’s Disease Progression Study (KH007)

Celebrating Last Patient In for Koneksa’s Parkinson’s Disease Progression Study (KH007)

Koneksa PD Day and MJFF

Digital Health Takes Center Stage at the MDS Conference

Koneksa Announces Regeneron Joins Data Syndication Program for Parkinson’s Digital Biomarkers Study

Koneksa Announces Merck Joins Data Syndication Partnership Program Around Parkinson’s Digital Biomarkers Observational Study

Contact

Technical Support

Products

Solutions

Therapeutic Areas

Insights

Company

Search Koneksa